
Verified
Neurocrine Biosciences
Pharmaceuticals
Founded: 1992
Headquarters: 12780 El Camino Real, San Diego, California 92130, United States
Overview
Location
California, United States
Headquarter
12780 El Camino Real, San Diego, California 92130, United States
Contact Number
18586177600
Industry
Pharmaceuticals
Contact Email
ir@neurocrine.com
Company Type
Public Company
Website
Founded
1992
CEO
Kevin C. Gorman
Codes
SIC Code 87,873 | NAICS Code 54,541
Annual Revenue
1.79 Billion USD
Total Funding
$1.5B
Recent Funding Amount
$502.2M
No of Funding Rounds
12
Founders
Kevin C. Gorman
Company Overview
Neurocrine Biosciences is a pharmaceutical company focused on the development of therapeutics for neuroinflammatory, neurodegenerative and neuropsychiatric disorders and diseases including Alzheimer's disease, diabetes, depression, and brain tumors. The company is headquartered in San Diego, California.
Top C-suite Members of Company
Connect with key decision-makers at Neurocrine Biosciences. View contact details of C-suite executives and leadership team.
| Name | Title | Contact | |
|---|---|---|---|
| Jude Onyia | Chief Scientific Officer | j****a@neurocrine.com | |
| Kyle Gano | Chief Executive Officer | k****o@neurocrine.com | |
| Ayesha Zierhut | Vice President | a****t@neurocrine.com | |
| Eric Benevich | Chief Commercial Officer | e****h@neurocrine.com | |
| Arline Nakanishi | Vice President | a****i@neurocrine.com | |
| Samir Siddhanti | Vice President | s****i@neurocrine.com | |
| Todd Tushla | Vice President | t****a@neurocrine.com | |
| Satjit Brar | Vice President | s****r@neurocrine.com | |
| Aaron Vosburgh | Vice President | a****h@neurocrine.com | |
| Randi Fain | Head Vice President | r****n@neurocrine.com | |
| Nina Thomas | Head Vice President | n****s@neurocrine.com |
Email Formats
Discover the email patterns used at Neurocrine Biosciences to connect with the right people.
| Email Format | Example | Percentage |
|---|---|---|
| firstname.lastname@company.com | john.doe@company.com | 45% |
| firstname@company.com | john@company.com | 30% |
| firstinitial.lastname@company.com | j.doe@company.com | 15% |
| firstname_lastname@company.com | john_doe@company.com | 10% |
View Email formats of the company.
Email Verification Tool
Get verified email addresses of any IBM employee. Enjoy 100 free lookups every month.
Enter a person's name or an email address to verify
Technology Stack
Frequently Asked Questions
What is the address of Neurocrine Biosciences's headquarters?
Neurocrine Biosciences is headquartered at 12780 El Camino Real, San Diego, California 92130, United States.
How can I contact Neurocrine Biosciences by phone?
You can reach Neurocrine Biosciences by calling their customer support number at 18586177600.
Which stock symbol does Neurocrine Biosciences trade under?
The stock ticker for Neurocrine Biosciences is NBIX.
What is the official website for Neurocrine Biosciences?
You can visit Neurocrine Biosciences's official website at www.neurocrine.com.
How much revenue does Neurocrine Biosciences generate?
Neurocrine Biosciences reports an annual revenue of approximately 1.79 Billion USD.
What is the SIC code for Neurocrine Biosciences?
The Standard Industrial Classification (SIC) code for Neurocrine Biosciences is 87,873.
What is the NAICS code for Neurocrine Biosciences?
Neurocrine Biosciences falls under the NAICS code 54,541.
How many people work at Neurocrine Biosciences?
Neurocrine Biosciences has a workforce of about 1500 employees.
Which technologies are used by Neurocrine Biosciences?
Neurocrine Biosciences utilizes technologies like Open Graph, Popper, HSTS.
Who is the Chief Executive Officer (CEO) of Neurocrine Biosciences?
The CEO of Neurocrine Biosciences is Kevin C. Gorman.
How can I get in touch with Neurocrine Biosciences?
To contact Neurocrine Biosciences, call 18586177600 or visit their website at www.neurocrine.com
Is Neurocrine Biosciences a publicly traded company?
Yes, Neurocrine Biosciences is publicly listed and trades under the stock symbol NBIX.
How much total funding has Neurocrine Biosciences secured so far?
To date, Neurocrine Biosciences has raised $1.5B across 12 funding round(s).
Which industry is Neurocrine Biosciences part of?
Neurocrine Biosciences operates in the Pharmaceuticals, Healthcare industry.
Who are the main competitors of Neurocrine Biosciences?
Key competitors of Neurocrine Biosciences include Intra-Cellular Therapies, ACADIA, Alnylam Pharmaceuticals, Exelixis
When did Neurocrine Biosciences complete its most recent funding round?
Neurocrine Biosciences latest funding round closed on May 02, 2017 with the amount of $502.2 Million
Who are the investors in Neurocrine Biosciences?
Neurocrine Biosciences is backed by 12 investors : Undisclosed, Undisclosed, National Institutes of Health and Undisclosed.